News
The global Suppositories Market, valued at US$1.56 billion in 2024 stood at US$1.63 billion in 2025 and is projected to ...
British packaging firm Mondi posted a near 17% fall in first-half pretax profit, citing a challenging macroeconomic environment.
British consumer healthcare group Haleon cut its annual revenue growth forecast after first-half growth missed expectations.
British consumer healthcare company Haleon lowered its annual organic revenue growth forecast to 3.5% on Thursday, citing ...
Over 220 participants convened along the banks of Sungai Gombak to celebrate "Hari Sungai Gombak" (Gombak River Day), held in ...
However, if the Fed adopts a more dovish stance and signals a potential rate cut in September, or if the BoJ adopts a more ...
"Amid Rising Private Labels and Digital-First Disruptors, the OTC Industry Faces a New Era of Competition. Explore Key Trends, Consumer Shifts, and Strategic Insights to Stay Ahead in a Rapidly ...
According to the latest study from BCC Research, "Over-the-Counter (OTC) Drugs, and Vitamins & Dietary Supplements: Global ...
Our approach to implementing social impact starts with our own purpose, to empower every person and every organisation on the planet to achieve more.
Haleon PLC closed 15.54% below its 52-week high of £4.20, which the company reached on May 30th.
Invezz.com - The FTSE 100 Index is hovering near its all-time high as investors wait for the upcoming earnings season. It was trading at £8,926 on Wednesday, down from the year-to-date high of £9,01.
Summary Haleon had alright organic growth thanks to product launches in China and an alright flu season, but just in the North American market. Guidance for 4-6% organic revenue growth hinges on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results